Versanis Bio

Oakland, United States

Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults.

$70.0M raised

Aug 2021

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Versanis Bio raised?

Versanis Bio has raised $70.0M in total funding. The most recent round was Series A. The last funding was announced in August 2021.

Who are Versanis Bio's investors?

Versanis Bio's investors include TCG Crossover, Atlas Venture, Medicxi, Aditum Bio.

Where is Versanis Bio headquartered?

Versanis Bio is headquartered in Oakland, United States.

What does Versanis Bio do?

Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults.

What stage is Versanis Bio at?

Versanis Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 31, 2021.

MLA

"Versanis Bio — Funding & Investors." VCBacked, August 31, 2021, https://www.vcbacked.co/company/versanis-bio. Accessed July 2, 2026.

APA

VCBacked. (2021). Versanis Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/versanis-bio

Wikipedia (cite web)

{{cite web |title=Versanis Bio — Funding & Investors |url=https://www.vcbacked.co/company/versanis-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 31, 2021.